SZSE Ticker: 000908

Hunan Jingfeng Pharmaceutical Co., Ltd.

湖南景峰医药股份有限公司

景峰医药

JINGFENG PHARMACEUTI

Listing Date: 1999-02-03

Board: Main Board - A Shares

Industry Classification: Manufacturing

Watching the market: Yingli Automobile and other 5 stocks stopped in seconds CFi.CN Zhongcai Network

Post date May 17, 2022 — 10:28 Post Lock

Jingfeng Medicine: Jingfeng has nothing to do with Zhejiang Arthur Medicine

Post date May 9, 2022 — 21:00 Post Lock

R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com

Post date May 9, 2022 — 04:42 Post Lock

A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline

Post date May 8, 2022 — 21:55 Post Lock

A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D

Post date May 8, 2022 — 20:56 Post Lock

Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball

Post date May 3, 2022 — 18:04 Post Lock

Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing_Individual Stock Information_Market Gold Online

Post date April 22, 2022 — 20:47 Post Lock

Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing-

Post date April 22, 2022 — 20:25 Post Lock

Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration

Post date April 22, 2022 — 20:18 Post Lock

Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration

Post date April 22, 2022 — 20:18 Post Lock

Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network

Post date April 20, 2022 — 07:46 Post Lock

China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results

Post date April 18, 2022 — 18:46 Post Lock

Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball

Post date April 4, 2022 — 22:18 Post Lock

Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology

Post date April 3, 2022 — 19:24 Post Lock